In patients with non-alcoholic steatohepatitis (NASH), there is a decrease in LPCAT3 expression in the liver [124], which leads to an increase in the amount of SFA in the inner mitochondrial membrane phospholipids and, consequently, to mitochondrial dysfunction and NASH [124]. This evidence concerns the gene LPCAT3 and metabolic dysfunction-associated steatohepatitis.